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ARTICLE
Genome-wide association study of knee pain
identiﬁes associations with GDF5 and
COL27A1 in UK Biobank
Weihua Meng 1,9, Mark J. Adams 2,9, Colin N.A. Palmer1, The 23andMe Research Team, Jingchunzi Shi3,
Adam Auton3, Kathleen A. Ryan4, Joanne M. Jordan 5, Braxton D. Mitchell4,6, Rebecca D. Jackson7,
Michelle S. Yau8, Andrew M. McIntosh 2 & Blair H. Smith 1
Knee pain is one of the most common musculoskeletal complaints that brings people to
medical attention. Approximately 50% of individuals over the age of 50 report an experience
of knee pain within the past 12 months. We sought to identify the genetic variants associated
with knee pain in 171,516 subjects from the UK Biobank cohort and seek supporting evidence
in cohorts from 23andMe, the Osteoarthritis Initiative, and the Johnston County Osteoar-
thritis Project. We identiﬁed two loci that reached genome-wide signiﬁcance in the UK
Biobank: rs143384, located in GDF5 (P= 1.32 × 10−12), a gene previously implicated in
osteoarthritis; and rs2808772, located near COL27A1 (P= 1.49 × 10−8). These ﬁndings were
supported in cohorts with self-reported osteoarthritis/radiographic knee osteoarthritis
without pain information. In this report on genome-wide association of knee pain, we iden-
tiﬁed two loci in or near GDF5 and COL27A1 that are associated with knee pain.
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The knee supports body weight when walking, standingupright and bending. Knee pain describes a speciﬁc area ofpain inside the knee or diffuse pain around knee area1. It is
one of the most common musculoskeletal complaints that bring
people to medical attention2. The knee pain experience varies
from person to person and can present as a dull ache to a sharp,
stabbing pain and from intermittent weight bearing pain to
persistent pain3.
Knee pain is highly prevalent in older individuals, with ~50%
of individuals over the age of 50 reporting an experience of knee
pain within the past 12 months4. In one US general population
cohort, knee pain prevalence has increased from 15.7 to 32.9% in
females and from 8.7 to 27.7% in males between 1983 and 2005,
regardless of knee osteoarthritis status5. In another estimate, the
prevalence of knee osteoarthritis in the USA increased from 8% in
1950s to 16% currently6. There are over eight million patients
suffering from knee osteoarthritis in the UK7. According to the
Global Burden of Diseases 2016, osteoarthritis including knee
osteoarthritis is the twelfth leading cause of years of life lived with
disability globally8. It is estimated that ~50% of all people with
knee osteoarthritis have reported knee pain symptoms and of
those without knee osteoarthritis, 20% have reported knee pain5.
There are many underlying mechanisms that can cause knee pain,
including injuries, gout and infection, as well as arthritis. Among
these, osteoarthritis is the most common cause, particularly in
people over the age of 505. People with knee pain will experience
progressive loss of knee function and declining quality of daily
life, and display increasing dependence in daily activities9. Fur-
ther, knee pain caused by osteoarthritis frequently accompanies
pain in other joints, such as hips and hands, which further
reduces quality of life10. The disease has generated huge economic
burdens to the health care systems across the world. For example,
although no ﬁgures exist speciﬁcally on knee osteoarthritis, the
total direct cost of osteoarthritis as a whole in the UK in 2010 was
around £1 billion and the corresponding total indirect cost of
osteoarthritis in 2010 was over £3.2 billion11.
Epidemiological studies have suggested multiple risk factors for
knee pain, including female sex, age, obesity, previous knee
injuries, knee-straining work and smoking12. Similar risk factors
are reported in studies of knee osteoarthritis speciﬁcally, which
also included kneeling and squatting as further risk factors12,13.
With aging populations and increasing rates of obesity, the pre-
valence of knee pain is likely to increase. Psychological factors are
also important risk factors of knee pain14. These environmental
and lifestyle factors are likely to interact with genetic factors, and
are important to understand in genetic association studies.
Genetic studies to date have focused on knee osteoarthritis, but
not knee pain more generally. Studies in siblings have reported
heritabilities for knee osteoarthritis as high as 0.6215. In a recent
large twin study, 45% of the respective variation for severe knee
osteoarthritis requiring joint replacement could be explained by
genetic factors16. The genetic architecture of knee osteoarthritis
was considered to follow an additive genetic model, involving
multiple genes or loci but each with small effect size17. Candidate
genes, including GDF5, COL9A1, IL1B, IL1RN, LRCH1, CLIP, TNA
and BMP2, have been reported to be associated with knee
osteoarthritis18–22. Genome-wide association studies (GWAS) have
also reported that the GDF5, DVWA, HLA-DQB1, BTNL2, COG5,
MCF2L, TP63, FTO, SUPT3H/RUNX2, GLN3/GLT8D1 and
LSP1P3 genes contribute speciﬁcally to knee osteoarthritis23–29.
Recently, Zengini et al. reported nine novel genetic loci associated
with osteoarthritis based on ﬁve different osteoarthritis deﬁni-
tions according to the self-reported status questionnaire and the
Hospital Episode Statistics data from the UK Biobank cohort30.
However, these analyses did not speciﬁcally focus on the
knee area.
To identify the genetic variants associated with knee pain, we
conducted a GWAS using the large UK Biobank cohort. We
deﬁned knee pain as ‘knee pain in the last month interfering with
usual activity’, based on the information available from the study
questionnaire. Since there are no knee pain GWAS summary
statistics available, we chose to support our genome-wide ﬁndings
on knee pain using three independent cohorts that deﬁned
osteoarthritis using either questionnaire data (i.e. 23andMe) or
radiographic criteria (i.e. the Osteoarthritis Initiative (OAI) and
the Johnston County Osteoarthritis Project (JoCo)).
Here, we use GWAS on knee pain to screen for genetic var-
iants; similar approaches have been taken for headache and back
pain using the UK Biobank cohort31,32.
Results
GWAS results. A total of 501,708 UK Biobank participants were
invited to respond to the pain questionnaire during the initial
assessment visit (2006–2010). Among those who responded,
29,995 participants selected the ‘Knee pain’ option (cases), and
197,149 participants selected the ‘None of the above’ option
(controls). After removing samples from non-British participants,
those who were related with another individual in the cohort and
those who failed quality control (QC), we identiﬁed 22,204 cases
(12,062 males and 10,142 females) and 149,312 controls (71,480
males and 77,832 females) for the GWAS association analysis and
there were 15,377,520 single nucleotide polymorphism (SNPs)
available for the GWAS analysis. The genomic control value
(lambda) was 1.06.
Table 1 summarises the clinical characteristics of these cases
and controls. There were statistical differences (P < 0.001) in sex,
age and body mass index (BMI) between cases and controls in the
UK Biobank samples.
We identiﬁed two SNP clusters that were associated with knee
pain, with genome-wide signiﬁcance (P < 5 × 10−8, Fig. 1,
Table 2). Four independent signiﬁcantly associated SNPs within
two clusters are shown in Table 2. All signiﬁcantly associated
SNPs (N= 107) in the discovery stage are shown in Supplemen-
tary Data 1.
The most signiﬁcantly associated SNP cluster was in the GDF5
gene in the chromosome 20q11.22 region with a P value of 1.32 ×
10−12 for rs143384 (A allele, beta: −0.008). The second most
signiﬁcantly associated cluster was in the LOC105376225 gene
(near the COL27A1 gene) in chromosome 9 with a lowest P value
of 1.49 × 10−8 for rs2808772 (A allele, beta: 0.006). The regional
plots for loci in GDF5 and COL27A1 are shown in Figs. 2 and 3.
The Q–Q plot of the GWAS in the discovery stage is shown in
Fig. 4. The SNP-based heritability of knee pain was 0.08 (standard
error= 0.03).
In the independent cohort 1 (23andMe, self-reported osteoar-
thritis), the P value for rs143384 was 2.44 × 10−9 in the 23andMe
Table 1 Clinical characteristics of knee pain and controls in
the UK Biobank
UK Biobank
Covariates Cases Controls P
Sex (male:
female)
12,062:10,142 71,480:77,832 <0.001
Age (years) 58.3 (7.64) 56.9 (7.97) <0.001
BMI (kg m−2) 28.6 (4.88) 26.7 (5.00) <0.001
A χ² test was used to test the difference of gender frequency between cases and controls and an
independent t test was used for other covariates. Continuous covariates were presented as
mean (standard deviation).
BMI body mass index
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cohort and in the independent cohorts 2 (OAI and JoCo cohorts,
radiographic knee osteoarthritis), the P value for rs143384 was
0.01 in the combined OAI and JoCo cohorts. The P values for
rs2808772 were 4.43 × 10−5 in the 23andMe (self-reported
osteoarthritis) and 0.36 in the combined OAI and JoCo cohorts
(radiographic knee osteoarthritis) (Table 2).
Gene, gene-set and tissue expression analysis by FUMA. In the
gene analysis, all the SNPs that are located within genes were
mapped to 19,436 protein coding genes. GDF5 demonstrated the
strongest association, with a P value of 1.09 × 10−11. The eleven
associated genes with P values <3 × 10−6 (0.05/19436) were
GDF5, UQCC1, CEP250, PODXL, C20orf173, SPAG4, MTMR3,
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Fig. 1 Manhattan plot of the GWAS on knee pain using the UK Biobank cohort
Table 2 Summary of the four independent and signiﬁcant SNPs associated with knee pain in the GDF5 and COL27A1 regions
Chromosome Gene SNPID Effective
allele in all
cohorts
Effective allele
frequency
discovery cohort
P value (beta) UK
Biobank
discovery cohort
P value (beta)
23andMe
independent cohort 1
P value (beta)
OAI–JoCo
independent
cohorts 2
9 LOC105376225
(near COL27A1)
rs919642 A 73.2% 2.29 × 10−8 (0.007) 4.84 × 10−12 (0.028) 0.88 (−0.008)
9 LOC105376225
(near COL27A1)
rs2808772 A 52.5% 1.49 × 10−8 (0.006) 4.43 × 10−5 (0.014) 0.36 (0.041)
20 GDF5 rs143384 A 60.0% 1.32 × 10−12 (−0.008) 2.44 × 10−9 (−0.021) 0.01 (−0.12)
20 GDF5 rs6120946 A 78.2% 6.81 × 10−9 (−0.008) 0.00071 (−0.014) 0.0074 (−0.16)
OAI–JoCo, the joint Osteoarthritis Initiative–Johnston County Osteoarthritis cohorts
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Fig. 2 Regional plot of the GDF5 gene region based on the GWAS on knee pain using the UK Biobank cohort
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ERGIC3, FBLN2, CPNE1 and CDC42SE2. The results are included
in Supplementary Table 1.
In the gene-set analysis, a total of 10,894 gene sets were tested.
The regulation pathway of breast_cancer_20q11_amplicon
demonstrated a P value of 2.59 × 10−8 and this was the only
gene set with a statistically signiﬁcant association (P < 5 × 10−6
(0.05/10,894)). The top ten gene sets from this analysis are shown
in Supplementary Table 2.
In the tissue expression analysis, none of the tissue types
demonstrated statistically signiﬁcant associations (P < 0.001),
either in the expression analysis of 30 general tissue types from
multiple organs or in the 53 speciﬁc tissue types within some of
these organs. See Supplementary Figs. 1 and 2.
Genetic correlation analysis by LD Hub. We identiﬁed multiple
signiﬁcant and negative genetic correlations for knee pain with
other traits (Supplementary Data 2). The genetic correlations (rg)
surviving multiple testing correction were: Years of schooling
2016 (rg=−0.29, P= 4.97 × 10−8), college completion (rg=
−0.36, P= 6.55 × 10−6), age of having ﬁrst baby (rg=−0.30, P=
1.92 × 10−5).
Discussion
In the ﬁrst reported GWAS of knee pain using the UK Biobank
resource, we identiﬁed variants in or near GDF5 and COL27A1,
which were subsequently supported in osteoarthritis cohorts from
the 23andMe, OAI and JoCo cohorts. In addition, we found that
knee pain was genetically and negatively correlated with a
number of socioeconomic factors, such as years of schooling and
college completion.
The generic pain question used by the UK Biobank is useful as
a screening tool and a useful step to test whether heterogeneous
pain phenotypes (such as knee pain) have genetic components at
all. The same question has been used to identify the genetic
variants of broadly deﬁned headache, and the ﬁndings were
similar to those for well-deﬁned migraine phenotypes31,33. The
beneﬁt of using UK Biobank on heterogeneous phenotypes will
allow researchers to overcome potential issues with reduced
power due to heterogeneity by using very large numbers to cut
through the statistical noise.
In this GWAS, we have identiﬁed two loci for knee pain. The
top locus was in the GDF5 gene in chromosome 20q11.2 with a
lowest P value of 1.32 × 10−12 for rs143384, while the locus itself
was 140 kb long spanning from the UQCC1 gene to the GDF5
gene containing 104 genome-wide positive SNPs (Supplementary
Data 1). The GDF5 gene encodes a secreted ligand of the trans-
forming growth factor-beta (TGF-beta) superfamily of proteins34.
This protein not only regulates the development of numerous
tissue and cell types, but also promotes the maintenance and
repair of synovial joint tissues, particularly cartilage and
bones34,35. Mutations in the gene can cause cartilage or bone
related disorders, such as chondrodysplasia, acromesomelic dys-
plasia and brachydactyly, suggesting a protective role in skeletal
development34. The GDF5 gene has been repeatedly reported to
be associated with osteoarthritis through genetic studies18,28.
Functional studies have suggested that knee morphology is pro-
foundly affected by Gdf5 absence in mice models, and
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downstream regulatory sequences mediate its effects by control-
ling Gdf5 expression in knee tissues36. It was also suggested that
osteoarthritis susceptibility mediated by variants in the GDF5
gene was not restricted to cartilage but joint wide37. Recently,
Capellini et al. combined the transgenic mice model with popu-
lation genetic analyses in humans to identify a GDF5 enhancer
that inﬂuences human growth and osteoarthritis risk38. Overall,
there is sufﬁcient and solid biological evidence relating the GDF5
gene with knee osteoarthritis, and we assume that this ﬁnding is
due to detection of knee pain caused by osteoarthritis, rather than
other pathologies.
The second SNP cluster was in the LOC105376225 area (which
is next to the COL27A1 gene) in chromosome 9 with a lowest P
value of 1.49 × 10−8 for rs2808772. There have been no speciﬁc
studies published about LOC105376225 and its relationship with
knee pain or knee osteoarthritis. However, the neighbouring
COL27A1 gene is clearly a good candidate gene. This gene
encodes a member of the ﬁbrillar collagen family, and plays a role
during the calciﬁcation of cartilage and the transition of cartilage
to bone39. Mutations in the COL27A1 gene have been reported to
be associated with the Steel syndrome. This syndrome is char-
acterised by bone changes, such as bilateral hip and radial head
dislocations, short stature, characteristic facies, fusion of carpal
bones, scoliosis, pes cavus and cervical spine anomalies40. Further,
the gene was reported to be associated with knee osteoarthritis in
the ﬁrst stage, but did not replicate in the second stage in a recent
GWAS study on knee osteoarthritis29. Thus, our large study on
knee pain has suggested that the COL27A1 gene might play a
contributing role for lesions in the knee area. Importantly,
polymorphisms in the gene have been associated with tendino-
pathy around the ankle joint41. The concordance between
radiographically deﬁned knee osteoarthritis and knee pain is quite
poor, with between 15 and 81% of patients diagnosed by radio-
graphic methods having pain symptoms42. It is therefore likely
that many people reporting knee pain have pain that is not bone
or cartilage related, but tendon related. It is possible that variants
in the COL27A1 gene could eventually affect the quality of the
tendons such as strength or ﬂexibility, which might lead to poor
tendon function, or their stability of the attachment to the patella,
which might also be knee pain related. A recent study has sug-
gested that a collagen gene COL11A2 play a role in pain sensi-
tisation after the development of osteoarthritis43. Interestingly,
the COL27A1 gene was not mentioned in GWAS on osteoarthritis
using the UK Biobank dataset44.
Our study focused on knee pain as a broad phenotype and the
genes that we identiﬁed are suggested to be related to knee
osteoarthritis. This suggests that the phenotype we chose was
genetically similar to the phenotype of knee osteoarthritis. The
relationship between knee pain and knee osteoarthritis deserves
further investigation. Studies have shown that people with end-
stage knee osteoarthritis all presented with knee pain45, but this
might not be the case for early stage knee osteoarthritis. As
described above, 20% of knee pain was not caused by knee
osteoarthritis and only 50% of knee osteoarthritis patients with
radiographic evidence had knee pain symptoms5. In addition, a
study has reported that 86% of people reporting knee pain will
develop knee osteoarthritis over 12 years46. Interestingly, the
hospital-diagnosed (N= 10,083 cases) osteoarthritis and self-
reported (N= 12,658 cases) osteoarthritis in the UK Biobank
were only half the size of those reported with knee pain in this
study (N= 22,204)30. This indicates the importance of treat knee
pain as a single entitle (like back pain) instead of solely being a
symptom of knee disorders. The Neale lab (http://www.nealelab.
is/uk-biobank) has performed over 2000 traits using the UK
Biobank dataset treating knee pain and knee osteoarthritis as
individual phenotypes.
The gene analysis by FUMA also supports our ﬁnding that
GDF5 was the strongest gene for knee pain. The gene-set analysis
by FUMA revealed that the regulation pathway of Nikolsky_-
breast_cancer_20q11_amplicon signalling was associated with the
phenotype we use. We noticed that GDF5 and this amplicon were
both located in chromosome 20q11 area and it was reported that
GDF5 protein regulates TGF-beta dependent angiogenesis in
breast carcinoma MCF-7 Cells47.
The SNP-based heritability for knee pain was 0.08 in our study,
which is the ﬁrst report of its kind. This low heritability suggests
the greater role of environmental than genetic factors in devel-
opment of knee pain, though this method of estimating herit-
ability is likely to miss some of the genetic contribution. We
identiﬁed that knee pain was genetically and negatively correlated
with a number of phenotypes such as years of schooling, college
completion and age of having ﬁrst baby. This means that those
with more years of schooling, those with completed college
education, and those who were older when they had their ﬁrst
baby were less likely to report current troublesome knee pain.
These factors could be related to lifestyle and occupation.
Using the CaTS power calculator (http://csg.sph.umich.edu/
abecasis/cats/), we had 80% power to identify SNP associations
with a signiﬁcance level of 5 × 10−8, based on 22,204 cases and
149,312 controls, assuming an additive model, a minor disease
allele frequency of 0.20, a genotypic relative risk of 1.06 and an
estimated prevalence of knee pain in the general population
of 0.2.
The major limitation of this study was that we used different
(though similar) phenotypes in discovery and supporting stages.
This was because of the phenotypic information that was avail-
able in the relevant and available cohorts, and the lack of any
existing relevant cohorts or datasets examining knee pain as a
phenotype. We deﬁned knee pain cases and controls based on the
responses by UK Biobank participants to a speciﬁc pain question.
This question focused on knee pain occurrence, sufﬁcient to cause
interference with activities, during the previous month. The
question does not ask information of the severity and frequency
and the exact area of knee pain. Therefore, our phenotyping
should be considered as widely deﬁned. The situation was similar
for the 23andMe cohort, in which disease status was also self-
reported via survey and self-reported osteoarthritis in the
23andMe cohort was not speciﬁc to the knee. Self-reported knee
pain has been widely used in other studies as well, though not for
studies of genetic associations48,49. The OAI and JoCo assessed
radiographic evidence of knee osteoarthritis but with limited
sample size. Although not true replications, these independent
cohorts suggest possible overlapping risk alleles among knee pain,
general osteoarthritis and knee osteoarthritis.
In conclusion, we have identiﬁed two loci (GDF5 and
COL27A1) for knee pain in a GWAS using the UK Biobank
resource and found evidence to support them in the 23andMe,
OAI and JoCo cohorts. In addition, we found several signiﬁcant
and negative genetic correlations between knee pain and a
number of educational phenotypes, suggesting that the genetic
aetiology of knee pain may also be related to these traits.
Methods
The participants and genetic information of all cohorts. Discovery cohort—UK
Biobank: Over 500,000 people aged between 40 and 69 years were recruited by the
UK Biobank cohort in 2006–2010 across England, Scotland and Wales. All parti-
cipants provided informed consent that their health records could be accessed for
research purposes. Further information about the UK Biobank cohort can be found
at www.ukbiobank.ac.uk. Ethical approval was granted by the National Health
Service National Research Ethics Service (reference 11/NW/0382).
DNA extraction and QC were standardised and the detailed methods can be
found at http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/DNA-
Extraction-at-UK-Biobank-October-2014.pdf. The Wellcome Trust Centre for
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Human Genetics at Oxford University was in charge of standard QC procedures
for genotyping results. The detailed QC steps can be found at http://biobank.ctsu.
ox.ac.uk/crystal/refer.cgi?id=155580.
In July 2017, the UK Biobank released the genetic information (including
directly genotyped genotypes and imputed genotypes) of 501,708 samples to all
approved researchers. The detailed QC steps of imputation were described by
Bycroft et al.50.
Independent cohort 1: 23andMe Inc: The 23andMe company is a privately held
personal genomics and biotechnology company based in the USA. It includes more
than 1,500,000 genotyped subjects who have consented to participate in research.
All participants included in the analyses provided informed consent and answered
surveys online according to 23andMe’s human subjects protocol, which was
reviewed and approved by Ethical & Independent Review Services, a private
institutional review board. The DNA extraction from saliva and the QC of the
genotyping and imputation results were all based on the company’s standardised
procedures. Further methodological details can be found in the supplementary ﬁle
of a previous publication51.
Independent cohorts 2: (1) The OAI is a prospective longitudinal study designed
to identify risk factors for the incidence and progression of symptomatic
tibiofemoral knee osteoarthritis. Participants aged between 45 and 79 years were
recruited at four different clinical sites in the USA. Details of the study protocol,
including recruitment procedures and eligibility criteria are available on the OAI
web site. (http://oai.epi-ucsf.org/datarelease/docs/StudyDesignProtocol.pdf). (2)
The JoCo is an ongoing, community-based study of the occurrence of knee and hip
osteoarthritis in African American and Caucasian residents, aged 45 years and
above from Johnston County, North Carolina in the USA. A total of 3068
individuals were recruited at baseline. A detailed description of the cohort has been
reported52. All participants provided informed consent.
Standard procedures of imputation and QC were applied when genotyping OAI
and JoCo samples. The detailed description of the cohorts has been previously
published29.
Phenotypic information of all cohorts in this study. Discovery cohort—UK
Biobank: We used a bespoke pain-related questionnaire adapted by the UK Bio-
bank, which included the question: ‘in the last month have you experienced any of
the following that interfered with your usual activities?’ The options were: (1)
Headache; (2) Facial pain; (3) Neck or shoulder pain; (4) Back pain; (5) Stomach or
abdominal pain; (6) Hip pain; (7) Knee pain; (8) Pain all over the body; (9) None of
the above; (10) Prefer not to say. More than one option could be selected. (UK
Biobank Questionnaire ﬁeld ID: 6159)
The knee pain cases in this study were those who selected the ‘knee pain’ option
for the above question, regardless of whether they had selected other options.
The controls in this study were those who selected the ‘None of the above’
option.
Independent cohort 1—23andMe, Inc: The 23andMe cohort used an online
survey to determine the phenotypic status of osteoarthritis of all participants.
Cases were deﬁned as those self-reported having been diagnosed or treated for
osteoarthritis.
Controls were deﬁned as those self-reporting as having not been diagnosed or
treated for osteoarthritis.
The cohort included 253,880 cases and 1,286,245 controls.
Independent cohorts 2—OAI and JoCo:
Cases. Knee osteoarthritis was evaluated with ﬁxed-ﬂexion posteroanterior
radiographs for OAI samples and for JoCo participants, weight-bearing
anteroposterior extended radiographs were taken during initial recruitments and
ﬁxed-ﬂexion posteroanterior radiographs were taken during follow-up. Cases were
those with deﬁnitive knee osteoarthritis, deﬁned as radiographic evidence of the
presence of deﬁnite osteophytes and possible joint space narrowing (Kellgren-
Lawrence grade ≥ 2) or total joint replacement in one or both knees. Controls were
those having no or doubtful evidence of OA (Kellgren-Lawrence grade= 0 or 1) in
both knees at all available time points.
These deﬁnitions were previously used by Yau et al.29. In the current study,
there were 2672 cases (2014 from OAI and 658 from JoCo) and 1776 controls (953
from OAI and 823 from JoCo).
Statistical analysis. GWAS analysis: In the discovery stage, the BGENIE (https://
jmarchini.org/bgenie/) was used as the main GWAS software, which was designed
for analysing the UK Biobank genetic datasets. Routine QC steps included removal
of SNPs with INFO scores <0.1, SNPs with minor allele frequency <0.5% or SNPs
that failed Hardy–Weinberg tests (P < 10−6). SNPs on the X and Y chromosomes
and mitochondrial SNPs were also removed. We further removed data from
individuals whose ancestry was not white British based on the principal component
analysis, those who were related to at least one other participant in the cohort (a
cutoff value of 0.025 in the generation of the genetic relationship matrix), and those
who failed QC. Association tests based on the linear association were performed
using BGENIE adjusting for age, sex, BMI, nine population principal components,
genotyping arrays and assessment centres. A χ² test was used to test for gender
differences between cases and controls. Age and BMI were compared using inde-
pendent t-test in IBM SPSS 22 (IBM Corporation, New York). A P value < 5 × 10−8
was considered to indicate a genome-wide association. Independent SNPs were
deﬁned as those that were not correlated (r2 < 0.6) with any other associated SNP.
GCTA (https://cnsgenomics.com/software/gcta/#Overview) was used to calculate
the narrow-sense heritability using a genomic relationship matrix calculated from
genotyped autosomal SNPs.
In the supporting stage (using independent cohorts), details of the identiﬁed
genome-wide positive and independent SNPs associated with knee pain from the
discovery stage were sent to 23andMe Inc and the combined OAI and JoCo
cohorts. The genome-wide positive and independent SNPs were deﬁned as those
with P value < 5 × 10−8 and with linkage disequilibrium value r2 < 0.6. The
23andMe and the combined OAI and JoCo cohorts then extracted the summary
statistics of these SNPs from their GWAS results, correspondingly.
23andMe performed GWAS on self-reported osteoarthritis in any joint using
the logistic regression method assuming an additive genetic model for allelic effects
adjusting for age, sex, ﬁve principal components and foue DNA chip platforms.
Participants were restricted to a set of individuals who had >97% European
ancestry, as determined through an analysis of local ancestry. A maximal set of
unrelated individuals was chosen for the GWAS analysis using a segmental
identity-by-descent estimation algorithm. Further details can be found in in the
supplementary ﬁle of a previous publication51.
The OAI and JoCo performed GWAS on radiographic knee osteoarthritis using
logistic regression assuming an additive genetic model for allelic effects adjusting
for age, sex, study site and principal components. Summary statistics from both
cohorts were then combined in a meta-analysis. Only participants of Caucasian
origin were included in the GWAS study. Standard procedures were used to
remove data from non-Caucasian individuals and related individuals. Further
details can be found in ref. 29.
GWAS-associated analysis: The FUMA web application was used as the main
annotation tool, and a Manhattan plot and a Q–Q plot were also generated by
this53. LocusZoom (http://locuszoom.org/) was used to provide regional
visualisation.
FUMA mainly provides three types of analysis: the gene analysis, the gene-set
analysis and the tissue expression analysis. In gene analysis, summary statistics of
SNPs were aggregated to the level of whole genes to test the associations between
genes with the phenotype. In gene-set analysis, groups of genes sharing certain
biological, functional or other characteristics were tested together to provide insight
into the involvement of speciﬁc biological pathways or cellular functions in the
genetic aetiology of a phenotype. The tissue expression analysis was based on GTEx
(https://www.gtexportal.org/home/), which is integrated into FUMA. Average gene
expression per tissue type was used as gene covariate to test for relationships
between gene expression in a speciﬁc tissue type and genetic associations with
knee pain.
To identify genetic correlations between knee pain and all other 234 complex
traits, we used linkage disequilibrium score regression through LD Hub v1.9.0
(available at http://ldsc.broadinstitute.org/ldhub/)54. The LD Hub estimates the
bivariate genetic correlations of a phenotype with 234 traits using individual SNP
allele effect sizes and the average linkage disequilibrium in a region. Those with P
values less than 2.1 × 10−4 (0.05/234) were considered signiﬁcant surviving
Bonferroni correction for multiple testing.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The summary statistics of the UK Biobank results on knee pain can be accessed through
https://ﬁgshare.com/articles/kneepaingwas/9611198. Data from 23andMe were obtained
under a data transfer agreement. Further information about obtaining access to the
23andMe Inc. summary statistics is available from: https://research.23andme.com/
collaborate/. Any other data relevant to the study that are not included in the article or its
supplementary materials are available from the authors upon reasonable request.
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